每年研究成果
每年研究成果
- 4結果
搜尋結果
-
2023
Corrigendum to “Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer” [Biochem. Biophys. Res. Commun. 680 (2023) 161–170, (S0006291X23010616), (10.1016/j.bbrc.2023.09.025)]
Chiang, C. W., Lin, Y. S., Chang, F. L., Lin, T. Y., Tsai, K. C., HuangFu, W. C. & Lee, Y. C., 12月 17 2023, 於: Biochemical and Biophysical Research Communications. 686, 149085.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
2020
Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))
Lin, C. F., Huang, H. L., Peng, C. Y., Lee, Y. C., Wang, H. P., Teng, C. M. & Pan, S. L., 1月 15 2020, 於: Toxicology and Applied Pharmacology. 387, 114858.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
2019
Correction to: Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway (Journal of Biomedical Science (2019) 26 (96) DOI: 10.1186/s12929-019-0588-8)
Wakabayashi, G., Lee, Y. C., Luh, F., Kuo, C. N., Chang, W. C. & Yen, Y., 12月 23 2019, 於: Journal of Biomedical Science. 26, 1, 98.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
2017
Correction: Production and characterization of neutralizing antibodies against Bungarus multicinctus snake venom [Applied and Environmental Microbiology, 82, 23, (2016), (6973-6982)] DOI:10.1128/AEM.01876-16
Lee, C. H., Lee, Y. C., Leu, S. J., Lin, L. T., Chiang, J. R., Hsu, W. J. & Yangd, Y. Y., 11月 1 2017, 於: Applied and Environmental Microbiology. 83, 22, e01949-17.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取